What is Autonomix Medical's market cap?

Autonomix Medical (AMIX) has a market capitalization of $4.0M and trades on NASDAQ.

Who are Autonomix Medical's competitors?

Autonomix Medical's key competitors include Medtronic, Boston Scientific, Abbott, and others. These companies compete in similar markets and product categories.

Where is Autonomix Medical headquartered?

Autonomix Medical is headquartered in United States of America and employs approximately 8 people. It has been publicly traded since 2024.

Autonomix Medical (AMIX) Stock Fundamentals & Financials

Autonomix Medical is a development-stage medical device company specializing in high-sensitivity neural sensing and targeted radiofrequency ablation.

Market cap

$4M-22.7%

Earnings

Q2 2026 report

August 12, 2026

EPS-$5.02Beat by $1.38

Read the full report

Next report

Nov 11, 2026 (In 1 week)

EPS estimate-$2.62

Competitors

By market cap

Johnson & Johnson$662.49B+45.5%

Abbott$180.95B-16.5%

Medtronic$124.22B+6.5%

Boston Scientific$61.9B-58.5%

Neuraxis$94.8M+240%

Aclarion, Inc.$5.7M+26.1%

Autonomix Medical$4.0M-37.3%

Adagio Medical$2.4M-92.0%

By revenue growth

Abbott+10.0%

Medtronic+9.8%

Boston Scientific+8.9%

Johnson & Johnson+7.8%

By net margin

Boston Scientific16.59%+2.2pp

Johnson & Johnson16.2%-11.1pp

Medtronic13.93%+0.3pp

Abbott9.75%-22.1pp

Profile

Autonomix Medical is a development-stage medical device company specializing in high-sensitivity neural sensing and targeted radiofrequency ablation. The company's proprietary platform utilizes a catheter-based system with microchip-enabled architecture to detect low-amplitude peripheral nerve signals from within the vascular system. Their core value proposition is a 'sense, treat, verify' approach designed to improve the precision of nerve-targeted therapies for disorders of the nervous system.

Competitive position

The company is an early-stage innovator attempting to solve the 'sensing problem' in peripheral nerve treatment by placing amplification at the point of detection, a capability not currently available in standard electrophysiology systems.

GeographiesUnited States, European Union

Customer segmentsHospitals, Specialized medical clinics

Business modelMedical device manufacturing, Razor-and-blade, Procedure-based recurring revenue

SuppliersThird-party contract manufacturers, Semiconductor suppliers, Specialized medical component providers, 3D printing services

CustomersHospital purchasing departments, Interventional pain management specialists, Oncology centers

CountryUnited States of America

Listed2024

Employees8.0

CEOBradley A. Hauser

SectorHealthcare

IndustryMedical - Devices

Websiteautonomix.com

FilingsSEC EDGAR

FAQ

What is Autonomix Medical's market cap?: Autonomix Medical (AMIX) has a market capitalization of $4.0M and trades on NASDAQ.
Who are Autonomix Medical's competitors?: Autonomix Medical's key competitors include Medtronic, Boston Scientific, Abbott, and others. These companies compete in similar markets and product categories.
Where is Autonomix Medical headquartered?: Autonomix Medical is headquartered in United States of America and employs approximately 8 people. It has been publicly traded since 2024.